Aion Therapeutic Inc. (CSE:AION)

Revenue by Product

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	FY 2023
Period Ending	Apr 30, 2023
Health and Wellness	367.48K

Revenue by Geography

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	FY 2023
Period Ending	Apr 30, 2023
United States	367.48K